(NYSE: AVNT) Avient's forecast annual revenue growth rate of 4.44% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.4%.
Avient's revenue in 2026 is $3,281,000,000.On average, 11 Wall Street analysts forecast AVNT's revenue for 2026 to be $316,400,076,150, with the lowest AVNT revenue forecast at $300,442,507,092, and the highest AVNT revenue forecast at $331,440,543,538. On average, 11 Wall Street analysts forecast AVNT's revenue for 2027 to be $327,405,296,190, with the lowest AVNT revenue forecast at $306,128,537,446, and the highest AVNT revenue forecast at $348,040,083,765.
In 2028, AVNT is forecast to generate $341,253,531,407 in revenue, with the lowest revenue forecast at $321,352,425,168 and the highest revenue forecast at $361,980,029,149.